181 related articles for article (PubMed ID: 33411992)
1. A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe.
Cherniakov I; Cohen-Barak O; Tiver R; Gillespie M; Kessler Y; Gutierrez M; Rasamoelisolo M; Li S; Shen H; Hallak H; Loupe PS; Smith M; Rabinovich-Guilatt L; Spiegelstein O
Clin Pharmacol Drug Dev; 2021 Sep; 10(9):1018-1027. PubMed ID: 33411992
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants.
Tang H; Civoli F; Tatarewicz S; Vandenkoornhuyse N; Finck B
Adv Ther; 2023 Nov; 40(11):4889-4906. PubMed ID: 37707674
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Open-Label Study Conducted to Evaluate the Bioequivalence of Pegfilgrastim-cbqv On-Body Injector Versus Prefilled Syringe in Healthy Male Participants.
Tang H; Civoli F; Tatarewicz S; Vandenkoornhuyse N; Finck B
Adv Ther; 2024 Mar; 41(3):991-1009. PubMed ID: 38180721
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence Between a New Omalizumab Prefilled Syringe With an Autoinjector or with a Needle Safety Device Compared with the Current Prefilled Syringe: A Randomized Controlled Trial in Healthy Volunteers.
Sangana R; Xu Y; Shah B; Tian X; Zack J; Shakeri-Nejad K; Kalluri S; Jones I; Ligueros-Saylan M; Taylor AF; Jain DK; Scosyrev E; Uddin A; Laurent N; Paganoni P
Clin Pharmacol Drug Dev; 2024 Jun; 13(6):611-620. PubMed ID: 38389387
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence of Canakinumab Injected Subcutaneously via an Autoinjector Device or a Prefilled Safety Syringe Device in Healthy Subjects.
Anumolu SS; Lindgren S; Vemula J; Floch D; Reynolds C; Wallny HJ; Sun H
Clin Pharmacol Drug Dev; 2018 Nov; 7(8):829-836. PubMed ID: 29676864
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic bridging approach for developing biologics-delivery devices: a case study with a golimumab autoinjector.
Xu Z; Marciniak SJ; Frederick B; Kim L; Zhuang Y; Davis HM; Zhou H
Clin Ther; 2015 Feb; 37(2):427-38. PubMed ID: 25438720
[TBL] [Abstract][Full Text] [Related]
7. Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers.
Zheng Y; Abuqayyas L; Megally A; Fuhr R; Sałapa K; Downie J; Colice G
Clin Ther; 2021 Jan; 43(1):142-155.e5. PubMed ID: 33380362
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetics of an adalimumab biosimilar SB5 administered via autoinjector or prefilled syringe in healthy subjects.
Shin D; Lee Y; Jeong D; Ellis-Pegler R
Drug Des Devel Ther; 2018; 12():3799-3805. PubMed ID: 30464411
[TBL] [Abstract][Full Text] [Related]
9. Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects.
Struemper H; Murtaugh T; Gilbert J; Barton ME; Fire J; Groark J; Fox NL; Roth D; Gordon D
Clin Pharmacol Drug Dev; 2016 May; 5(3):208-15. PubMed ID: 27163500
[TBL] [Abstract][Full Text] [Related]
10. A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects.
Bush J; Kawakami K; Muniz R
BMC Pharmacol Toxicol; 2019 Dec; 20(1):87. PubMed ID: 31888742
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and tolerability of prefilled syringe and auto-injector presentations of MSB11456: results of a randomized, single-dose study in healthy adults.
Tomaszewska-Kiecana M; Dryja A; Ullmann M; Petit-Frere C; Illes A; Dagres C; Monnet J
Expert Rev Clin Immunol; 2023 Apr; 19(4):447-455. PubMed ID: 36789991
[TBL] [Abstract][Full Text] [Related]
12. Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y
Zenklusen I; Hsin CH; Schilling U; Kankam M; Krause A; Ufer M; Dingemanse J
Clin Pharmacokinet; 2022 May; 61(5):687-695. PubMed ID: 34961905
[TBL] [Abstract][Full Text] [Related]
13. The Pharmacokinetics and Relative Bioavailability of Mepolizumab 100 mg Liquid Formulation Administered Subcutaneously to Healthy Participants: A Randomized Trial.
Shabbir S; Pouliquen IJ; Bentley JH; Bradford ES; C Kaisermann M; Albayaty M
Clin Pharmacol Drug Dev; 2020 Apr; 9(3):375-385. PubMed ID: 31317668
[TBL] [Abstract][Full Text] [Related]
14. Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies.
Stauffer VL; Sides R; Lanteri-Minet M; Kielbasa W; Jin Y; Selzler KJ; Tepper SJ
Patient Prefer Adherence; 2018; 12():1785-1795. PubMed ID: 30271122
[TBL] [Abstract][Full Text] [Related]
15. Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.
Zhuang Y; de Vries DE; Marciniak SJ; Liu H; Zhou H; Davis HM; Leon F; Raible D; Xu Z
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):570-576. PubMed ID: 28052588
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, open-label, 2-arm parallel study to compare the pharmacokinetics, safety and tolerability of AVT02 administered subcutaneously via prefilled syringe or autoinjector in healthy adults.
Wynne C; Schwabe C; Stroissnig H; Dias R; Sobierska J; Guenzi E; Otto H; Sattar A; Haliduola HN; Edwald E; Berti F
Expert Opin Biol Ther; 2023; 23(8):773-780. PubMed ID: 36197309
[TBL] [Abstract][Full Text] [Related]
17. Fremanezumab autoinjector pen for the prevention of migraine.
Weatherall MW
Ther Deliv; 2021 Sep; 12(9):645-650. PubMed ID: 34392708
[TBL] [Abstract][Full Text] [Related]
18. Comparative Bioavailability of Hydroxyprogesterone Caproate Administered via Intramuscular Injection or Subcutaneous Autoinjector in Healthy Postmenopausal Women: A Randomized, Parallel Group, Open-label Study.
Krop J; Kramer WG
Clin Ther; 2017 Dec; 39(12):2345-2354. PubMed ID: 29191450
[TBL] [Abstract][Full Text] [Related]
19. Phase 3, open-label, randomized study of the pharmacokinetics, efficacy and safety of ixekizumab following subcutaneous administration using a prefilled syringe or an autoinjector in patients with moderate-to-severe plaque psoriasis (UNCOVER-A).
Callis Duffin K; Bagel J; Bukhalo M; Mercado Clement IJ; Choi SL; Zhao F; Gill A; Pangallo B; Shuler C; Mallbris L; Jackson K
J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):107-113. PubMed ID: 27500949
[TBL] [Abstract][Full Text] [Related]
20. Two-Way Crossover Phase 1 Bioequivalence and Safety Studies in Healthy Adults for a Ready-to-Use, Room-Temperature, Liquid-Stable Glucagon Administered by Autoinjector, Prefilled Syringe, or Vial and Syringe.
Junaidi MK; Krecic MR; Close NC; Conoscenti V
J Diabetes Sci Technol; 2023 Jun; ():19322968231179164. PubMed ID: 37291796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
